Publications
Detailed Information
Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Sue K. | - |
dc.contributor.author | Andreotti, Gabriella | - |
dc.contributor.author | Sakoda, Lori C. | - |
dc.contributor.author | Gao, Yu-Tang | - |
dc.contributor.author | Chen, Jinbo | - |
dc.contributor.author | Rosenberg, Philip S. | - |
dc.contributor.author | Wang, Bing-Sheng | - |
dc.contributor.author | Zhang, Bai-He | - |
dc.contributor.author | Chanock, Stephen | - |
dc.contributor.author | Hsing, Ann W. | - |
dc.contributor.author | Yeager, Meredith | - |
dc.contributor.author | Han, Tian-Quan | - |
dc.contributor.author | Shen, Ming-Chang | - |
dc.contributor.author | Chen, Bingshu E. | - |
dc.contributor.author | Rashid, Asif | - |
dc.date.accessioned | 2012-06-08T07:48:28Z | - |
dc.date.available | 2012-06-08T07:48:28Z | - |
dc.date.issued | 2009-04 | - |
dc.identifier.citation | CARCINOGENESIS; Vol.30 4; 606-614 | ko_KR |
dc.identifier.issn | 0143-3334 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76926 | - |
dc.description.abstract | Biliary tract cancers, encompassing gallbladder, extrahepatic bile duct and ampulla of Vater cancers, are uncommon but often fatal malignancies. Hormone-related factors, including parity, oral contraceptive use, obesity, and gallstones, have been implicated in the etiology of these cancers. To further clarify the role of hormones in biliary tract cancers and biliary stones, we genotyped 18 single-nucleotide polymorphisms (SNPs) in nine genes involved in steroid hormone biosynthesis, metabolism and transport in a population-based case-control study in Shanghai, China. This study included subjects who completed an interview and provided blood, which totaled 411 biliary tract cancer and 893 biliary stone patients and 786 healthy Shanghai residents. The CYP1A1 IVS1 + 606 (rs2606345) T allele was associated with gallbladder [odds ratio (OR) = 2.0, 95% confidence interval (CI), 1.3-3.0] and bile duct cancers (OR = 1.8, 95% CI = 1.1-3.1), whereas the CYP1A1 Ex7 + 131 (rs1048943) G allele was associated with ampulla of Vater cancer (OR = 2.9, 95% CI = 1.5-5.4). After taking into account multiple comparisons for SNPs within each gene, CYP1A1 was significantly associated with gallbladder (P = 0.004) and ampulla of Vater cancers (P = 0.01), but borderline with bile duct cancer (P = 0.06). The effect of CYP1A1 IVS1 + 606 on gallbladder cancer was more pronounced among non-obese (body mass index < 23) (OR = 3.3, 95% CI = 1.8-6.1; P interaction = 0.001). Among women taking oral contraceptives, the effect of SHBG Ex8 + 6 (rs6259) on gallbladder cancer (OR = 6.7, 95% CI = 2.2-20.5; P interaction = 0.001) and stones (OR = 2.3, 95% CI = 1.1-4.9; P-interaction = 0.05) was statistically significant. Our findings suggest that common variants in hormone-related genes contribute to the risk of biliary tract cancers and stones, possibly by modulating hormone metabolism. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | OXFORD UNIV PRESS | ko_KR |
dc.title | Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 박수경 | - |
dc.identifier.doi | 10.1093/carcin/bgp024 | - |
dc.citation.journaltitle | CARCINOGENESIS | - |
dc.description.citedreference | Hsing AW, 2008, CANCER RES, V68, P6442, DOI 10.1158/0008-5472.CAN-08-0444 | - |
dc.description.citedreference | Hsing AW, 2008, BRIT J CANCER, V99, P811, DOI 10.1038/sj.bjc.6604616 | - |
dc.description.citedreference | Hsing AW, 2008, INT J CANCER, V122, P1849, DOI 10.1002/ijc.23251 | - |
dc.description.citedreference | Hsing AW, 2007, BRIT J CANCER, V97, P1577, DOI 10.1038/sj.bjc.6604047 | - |
dc.description.citedreference | Chen CH, 2006, J GASTROEN HEPATOL, V21, P1737, DOI 10.1111/j.1440-1746.2006.04381.x | - |
dc.description.citedreference | Rosenberg PS, 2006, STAT MED, V25, P3134, DOI 10.1002/sim.2407 | - |
dc.description.citedreference | Hou LF, 2006, INT J CANCER, V118, P2847, DOI 10.1002/ijc.21708 | - |
dc.description.citedreference | Sakoda LC, 2006, CARCINOGENESIS, V27, P1251, DOI 10.1093/carcin/bgi314 | - |
dc.description.citedreference | Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054 | - |
dc.description.citedreference | Randi G, 2006, INT J CANCER, V118, P1591, DOI 10.1002/ijc.21683 | - |
dc.description.citedreference | Panzer C, 2006, J SEX MED, V3, P104, DOI 10.1111/j.1743-6109.2005.00198.x | - |
dc.description.citedreference | HSING AW, 2006, CANC EPIDEMIOLOGY PR, P787 | - |
dc.description.citedreference | Dhiman RK, 2006, EXPERT OPIN DRUG SAF, V5, P117, DOI 10.1517/14740338.5.1.117 | - |
dc.description.citedreference | Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457 | - |
dc.description.citedreference | Packer BR, 2004, NUCLEIC ACIDS RES, V32, pD528, DOI 10.1093/nar/gkh005 | - |
dc.description.citedreference | Fernandez E, 2003, INT J CANCER, V105, P408, DOI 10.1002/ijc.11083 | - |
dc.description.citedreference | Pasquali R, 2002, J ENDOCRINOL INVEST, V25, P893 | - |
dc.description.citedreference | Gallus S, 2002, INT J CANCER, V99, P762, DOI 10.1002/ijc.10411 | - |
dc.description.citedreference | Kamat A, 2002, TRENDS ENDOCRIN MET, V13, P122 | - |
dc.description.citedreference | Tsuchiya Y, 2002, J EXP CLIN CANC RES, V21, P119 | - |
dc.description.citedreference | Schaid DJ, 2002, AM J HUM GENET, V70, P425 | - |
dc.description.citedreference | PARKIN DM, 2002, IARC SCI PUBLICATION, V155 | - |
dc.description.citedreference | Simon JA, 2001, ANN INTERN MED, V135, P493 | - |
dc.description.citedreference | Schwarz D, 2000, PHARMACOGENETICS, V10, P519 | - |
dc.description.citedreference | Uhler ML, 2000, MENOPAUSE, V7, P162 | - |
dc.description.citedreference | Bartsch H, 2000, CANCER EPIDEM BIOMAR, V9, P3 | - |
dc.description.citedreference | Lowenfels AB, 1999, HEPATO-GASTROENTEROL, V46, P1529 | - |
dc.description.citedreference | Khan ZR, 1999, AM J GASTROENTEROL, V94, P149 | - |
dc.description.citedreference | Hsing AW, 1998, INT J CANCER, V75, P368 | - |
dc.description.citedreference | Zatonski WA, 1997, J NATL CANCER I, V89, P1132 | - |
dc.description.citedreference | Tavani A, 1996, EUR J CANCER PREV, V5, P241 | - |
dc.description.citedreference | Feigelson HS, 1996, J CELL BIOCHEM, P15 | - |
dc.description.citedreference | EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921 | - |
dc.description.citedreference | TAIOLI E, 1995, TOXICOL LETT, V77, P357 | - |
dc.description.citedreference | CHOW WH, 1994, CANCER CAUSE CONTROL, V5, P267 | - |
dc.description.citedreference | MOERMAN CJ, 1994, INT J CANCER, V57, P146 | - |
dc.description.citedreference | COSMA G, 1993, J TOXICOL ENV HEALTH, V40, P309 | - |
dc.description.citedreference | MILNE R, 1991, CONTRACEPTION, V43, P667 | - |
dc.description.citedreference | EVERSON GT, 1991, J CLIN INVEST, V87, P237 | - |
dc.description.citedreference | KRITZSILVERSTEIN D, 1990, J CLIN EPIDEMIOL, V43, P687 | - |
dc.description.citedreference | KATO K, 1989, JPN J CANCER RES, V80, P932 | - |
dc.description.citedreference | YEN S, 1987, CANCER, V59, P2112 | - |
dc.description.citedreference | BERNSTEIN L, 1985, J NATL CANCER I, V74, P741 | - |
dc.description.citedreference | SIITERI PK, 1982, RECENT PROG HORM RES, V38, P457 | - |
dc.description.citedreference | BALL P, 1980, ACTA ENDOCRINOL S93, V232, P1 | - |
dc.description.citedreference | ARMITAGE P, 1955, BIOMETRICS, V11, P375 | - |
dc.description.tc | 6 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.